[1] Jordan M A, Wilson L. Microtubules as a target for anticancer drugs[J]. Nat Rev Cancer, 2004, 4(4):253-65.
[2] Dominguez-Brauer C, Thu K L, Mason J M, et al. Targeting Mitosis in Cancer: Emerging Strategies[J]. Mol Cell, 2015, 60(4):524-36.
[3] Kavallaris M. Microtubules and resistance to tubulin-binding agents[J]. Nat Rev Cancer, 2010, 10(3):194-204.
[4] Rath O, Kozielski F. Kinesins and cancer[J]. Nat Rev Cancer, 2012, 12(8):527-39.
[5] Miki H, Okada Y, Hirokawa N. Analysis of the kinesin superfamily: insights into structure and function[J]. Trends Cell Biol, 2005, 15(9):467-76.
[6] Diefenbach R J, Mackay J P, Armati P J, et al. The C-terminal region of the stalk domain of ubiquitous human kinesin heavy chain contains the binding site for kinesin light chain[J]. Biochemistry, 1998, 37(47):16663-70.
[7] Kondo S, Sato-Yoshitake R, Noda Y, et al. KIF3A is a new microtubule-based anterograde motor in the nerve axon[J]. J Cell Biol, 1994, 125(5):1095-107.
[8] Lu W, Gelfand V I. Moonlighting Motors: Kinesin, Dynein, and Cell Polarity[J]. Trends Cell Biol, 2017, 27(7):505-514.
[9] De S, Cipriano R, Jackson M W, et al. Overexpression of kinesins mediates docetaxel resistance in breast cancer cells[J]. Cancer Res, 2009, 69(20):8035-42.
[10] Li Y, Guo H, Wang Z, et al. Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells[J]. Exp Cell Res, 2020, 395(2):112212.
[11] Shen T, Yang L, Zhang Z, et al. KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells[J]. Dis Markers, 2019, 2019:4863182.
[12] Ren X, Chen X, Ji Y, et al. Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome[J]. Aging (Albany NY), 2020, 12(24):25878-25894.
[13] Zhang L, Zhu G, Wang X, et al. Genomewide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma[J]. Oncol Rep, 2019, 42(3):1017-1034.
[14] Li X, Huang W, Huang W, et al.
[15] Goldman M J, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform[J]. Nat Biotechnol, 2020, 38(6):675-678.
[16] Liu J, Lichtenberg T, Hoadley K A, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics[J]. Cell, 2018, 173(2):400-416 e11.
[17] Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data[J]. Nat Commun, 2013, 4:2612.
[18] Tamborero D, Rubio-Perez C, Muinos F, et al. A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations[J]. Clin Cancer Res, 2018, 24(15):3717-3728.
[19] Goel S, Decristo M J, Watt A C, et al. CDK4/6 inhibition triggers anti-tumour immunity[J]. Nature, 2017, 548(7668):471-475.
[20] Vinay D S, Ryan E P, Pawelec G, et al. Immune evasion in cancer: Mechanistic basis and therapeutic strategies[J]. Semin Cancer Biol, 2015, 35 Suppl:S185-S198.
[21] Malta T M, Sokolov A, Gentles A J, et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation[J]. Cell, 2018, 173(2):338-354 e15.
[22] Sadreddini S, Baradaran B, Aghebati-Maleki A, et al. Immune checkpoint blockade opens a new way to cancer immunotherapy[J]. J Cell Physiol, 2019, 234(6):8541-8549.
[23] Wordeman L. How kinesin motor proteins drive mitotic spindle function: Lessons from molecular assays[J]. Semin Cell Dev Biol, 2010, 21(3):260-8.
[24] Hirokawa N, Noda Y, Tanaka Y, et al. Kinesin superfamily motor proteins and intracellular transport[J]. Nat Rev Mol Cell Biol, 2009, 10(10):682-96.
[25] Wood K. Past and future of the mitotic spindle as an oncology target[J]. Current Opinion in Pharmacology, 2001, 1(4):370-377.
[26] Jiao S, Subudhi S K, Aparicio A, et al. Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy[J]. Cell, 2019, 179(5):1177-1190 e13.
[27] Quail D F, Joyce J A. Microenvironmental regulation of tumor progression and metastasis[J]. Nat Med, 2013, 19(11):1423-37.
[28] Wang H, Wu X, Chen Y. Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer[J]. Front Oncol, 2019, 9:1212.
[29] Baghban R, Roshangar L, Jahanban-Esfahlan R, et al. Tumor microenvironment complexity and therapeutic implications at a glance[J]. Cell Commun Signal, 2020, 18(1):59.
[30] Chambers A F, Groom A C, Macdonald I C. Dissemination and growth of cancer cells in metastatic sites[J]. Nat Rev Cancer, 2002, 2(8):563-72.